L-Glutamate and γ-aminobutyric acid efflux from rat cerebrocortical synaptosomes: Modulation by κ- and μ- but not δ- and opioid receptor like- 1 receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 3, 1999, Pages 1365-1371

  Sbrenna, Simone ^a,b   Marti, Matteo ^a   Morari, Michele ^a   Calo, Girolamo ^a   Guerrini, Remo ^a   Beani, Lorenzo ^a   Bianchi, Clementina ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b Section of Pharmacology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; DELTA OPIATE RECEPTOR; DELTORPHIN; ENDOMORPHIN 1; GLUTAMIC ACID; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NEUROTRANSMITTER; NOCICEPTIN; NORBINALTORPHIMINE; OPIATE AGONIST; OPIATE RECEPTOR; TETRODOTOXIN;

AMINO ACID TRANSPORT; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY;

ANIMALS; CEREBRAL CORTEX; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; MALE; OPIOID PEPTIDES; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; STIMULATION, CHEMICAL; SYNAPTOSOMES; TETRODOTOXIN;

EID: 0032725891     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Adam-Vizi V (1992) External calcium-independent release of neurotransmitters. J Neurochem 58:395-405.
2. Bradford HF, Crowder JM and White EJ (1986) Inhibitory actions of opioid compounds on calcium fluxes and neurotransmitter release from mammalian cerebral cortical slices. Br J Pharmacol 88:87-93.
3. Bunzow JR, Saez C, Mortrud M, Bouvier C, Williams JT, Low M and Grandy DK (1994) Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type. FEBS Lett 347:284-288.
4. Calo G, Guerrini R, Bigoni R, Rizzi A, Bianchi C, Regoli D and Salvadori S (1998a) Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist. J Med Chem 41:3360-3366.
5. Calo G, Rizzi A, Marzola G, Guerrini R, Salvadori S, Beani L, Regoli D and Bianchi C (1998b) Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay. Br J Pharmacol 125:373-378.
6. Canavero S and Bonicalzi V (1998) The neurochemistry of central pain: Evidence from clinical studies, hypothesis and therapeutic implications. Pain 74:109-114.
7. Carpenter KJ and Dickenson AH (1998) Evidence that [Phel 89 (CH2-NH)Gly2]nociceptin-(1-13)-NH2, a peripheral ORL 1 receptor antagonist, acts as an agonist in the rat spinal cord. Br J Pharmacol 125:949-950.
8. Dhawan BN, Cesselin F, Raughubir R, Reisine T, Bradley PB, Portoghese PS and Hamon M (1996) International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol Rev 48:567-592.
9. Erspamer V, Melchiorri P, Falconieri-Erspamer G, Negri L and Corsi R (1989) Deltorphins: A family of naturally occurring peptides with high affinity and selectivity for delta opioid binding sites. Proc Natl Acad Sci USA 86:5188-5192.
10. Faden AI (1996) Neurotoxic versus neuroprotective actions of endogenous opioid peptides: Implications for treatment of CNS injury. NIDA Res Monogr 163:318-330.
11. Gong J, Strong JA, Zhang S, Yue X, DeHaven RN, Daubert JD, Cassel JA, Yu G, Mansson E and Yu L (1998) Endomorphins fully activate a cloned mu opioid receptor FEBS Lett 439:152-156.
12. Guerrini R, Calo G, Rizzi A, Bigoni R, Bianchi C, Salvadori S and Regoli D (1998) A new selective antagonist of the nociceptin receptor. Br J Pharmacol 123:163-165.
13. Kalyuzhny AE and Wessendorf MW (1998) Relationship of μ and δ-opioid receptors to GABAergic neurons in the central nervous system, including antinociceptive brainstem circuits. J Comp Neurol 392:528-547.
14. Lindroth P and Mopper K (1979) High performance liquid chromatographic determination of subpicomole amounts of aminoacids by precolumn fluorescence derivatization with o-phthaldehyde. Anal Chem 51:1667-1674.
15. Mansour A, Fox CA, Akil H and Watson SJ (1995) Opioid-receptor mRNA expression in the rat CNS: Anatomical and functional implications. Trends Neurosci 18:22-29.
16. +-efflux from mouse brain synaptosomes. J Pharmocol Exp Ther 247:833-841.
17. Meunier JC (1997) Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. Eur J Pharmacol 340:1-15.
18. Meunier JC, Mollereau C, Toll L, Suaudeau C, Moisand C, Alvinerie P, Butour JL, Guillemot JC, Ferrara P, Monsarrat B, Mazarguil H, Vassart G, Parmentier M and Costentin J (1995) Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature (Lond) 377:532-535.
19. Mollereau C, Parmentier M, Mailleux P, Butour JL, Moisand C, Chalon P, Caput D, Vassart G and Meunier JC (1994) ORL1, a novel member of the opioid receptor family: Cloning, functional expression and localization. FEBS Lett 341:33-38.
20. Monteillet-Agius G, Fein J, Anton B and Evans C (1998) ORL-1 and mu opioid receptor antisera label different fibers in areas involved in pain processing. J Comp Neurol 399:373-383.
21. Morari M, Sbrenna S, Marti M, Caliari C, Bianchi C and Beani L (1998) NMDA and non-NMDA ionotropic glutamate receptors modulate striatal acetylcholine release via pre- and postsynaptic mechanisms. J Neurochem 71:2006-2017.
22. 3H]noradrenaline release from rat brain cortex synaptosomes: Further evidence for a presynaptic localization of mu-opioid receptors. J Neurochem 48:1043-1047.
23. + evoked glutamate release from rat cerebrocortical slices. Br J Pharmacol 119:1081-1083.
24. + evoked glutamate release from rat cerebrocortical slices. Neurosci Lett 218:79-82.
25. Okawa H, Nicol B, Bigoni R, Hirst RA, Calo G, Guerrini R, Rowbotham DJ, Smart D, McKnight AT and Lambert DG (1999) Comparison of the effects of [Phe1 89 (CH2-NH)Gly2]nociceptin-(1-13)-NH2 in rat brain, rat vas deferens and CHO cells expressing recombinant human nociceptin receptors. Br J Pharmacol 127:123-130.
26. Pan ZZ (1998) Mu-opposing actions of the kappa-opioid receptor. Trends Pharmacol Sci 19:94-98.
27. Pasternak GW (1993) Pharmacological mechanisms of opioid analgesics. Clin Neuropharmacol 16:1-18.
28. Schlicker E, Werthwein M, Kathmann M and Bauer U (1998) Nociceptin inhibits noradrenaline release in the mouse brain cortex via presynaptic ORL1 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 358:418-422.
29. 35S]GTP-γS binding in mMOR-CHO cells and rat thalamus. J Pharmacol Exp Ther 286:496-505.
30. Simonato M (1996) The neurochemistry of morphine addiction in the neocortex. Trends Pharmacol Sci 17:410-415.
31. 3H-d-aspartate outflow in the rat hippocampus in vitro. Neurochem Int 26:555-560.
32. 3H]-5HT release from rat cerebral cortex. Br J Pharmacol 126 (Proc Suppl):266P.
33. ++ and glutamate release. J Neurochem 53:1693-1699.
34. Varani K, Rizzi A, Calo G, Bigoni R, Toth G, Guerrini R, Gessi S, Salvadori S, Borea PA and Regoli D (1999) Pharmacology of [Tyr1]nociceptin analogs: Receptor binding and bioassay studies. Naunyn-Schmiedeberg's Arch Pharmacol, in press.
35. VonVoigtlander PF, Lahti RA and Ludens JH (1983) U-50,488: A selective and structurally novel non-mu (kappa) opioid agonist. J Pharmacol Exp Ther 224:7-12.
36. Wu LG and Saggau P (1997) Presynaptic inhibition of elicited neurotransmitter release. Trends Neurosci 20:204-212.
37. Xiang JZ, Adamson P, Brammer MJ and Campbell IC (1990) The kappa-opiate agonist U50488H decreases the entry of 45Ca into rat cortical synaptosomes by inhibiting N- but not L-type calcium channels. Neuropharmacology 29:439-444.
38. Zadina JE, Hackler L, Ge LJ and Kastin AJ (1997) A potent and selective endogenous agonist of the mu-opiate receptor. Nature (Lond) 386:499-502.